Работы, на которые ссылается эта работа

Работ: 21

Работа: Social network-based ethical analysis of COVID-19 vaccine supply policy in three Central Asian countries

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
Fernando P. Polack, Stephen J. Thomas, Nicholas Kitchin +26
Статья2020Цитирований: 8
ABI
Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia
Denis Y. Logunov, Inna V. Dolzhikova, Dmitry V. Shcheblyakov +28
Статья2021Цитирований: 5
ABI
Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: a systematic review and meta-analysis
Derek K. Chu, Elie A Akl, Stephanie Duda +39
Обзорная статья2020Цитирований: 4
ABI
Recombinant vaccines for COVID-19
Tushar Yadav, Nishant Srivastava, Gourav Mishra +4
Обзорная статья2020Цитирований: 3
ABI
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
Merryn Voysey, Sue Ann Costa Clemens, Shabir A. Madhi +97
Статья2020Цитирований: 3
ABI
International Ethical Guidelines for Health-related Research involving Humans
Council for International Organizations of Medical Sciences (CIOMS)
Отчёт2016Цитирований: 3
ABI
The ethics of ‘public understanding of ethics’—why and how bioethics expertise should include public and patients’ voices
Silke Schicktanz, Mark Schweda, Brian Wynne
Статья2011Цитирований: 2
ABI
Opinion summarization methods: Comparing and extending extractive and abstractive approaches
Roque López, Thiago Alexandre Salgueiro Pardo
Статья2017Цитирований: 2
ABI
Vaccine Efficacy Needed for a COVID-19 Coronavirus Vaccine to Prevent or Stop an Epidemic as the Sole Intervention
Sarah M. Bartsch, Kelly J. O’Shea, Marie C. Ferguson +8
Статья2020Цитирований: 2
ABI
Good reasons to vaccinate: mandatory or payment for risk?
Julian Savulescu
Статья2020Цитирований: 2
ABI
COVID-19 response in central Asia
Vijay Shankar Balakrishnan
Статья2020Цитирований: 2
ABI
Challenges in creating herd immunity to SARS-CoV-2 infection by mass vaccination
Roy M. Anderson, Carolin Vegvari, James E. Truscott +1
Статья2020Цитирований: 2
ABI
Ethical allocation of future COVID-19 vaccines
Rohit Gupta, Stephanie R. Morain
Статья2020Цитирований: 2
ABI
COVID-19 mortality risk assessment: An international multi-center study
Dimitris Bertsimas, Galit Lukin, Luca Mingardi +16
Статья2020Цитирований: 2
ABI
Covax must go beyond proportional allocation of covid vaccines to ensure fair and equitable access
Lisa Herzog, Ole Frithjof Norheim, Ezekiel Emanuel +1
Статья2021Цитирований: 2
ABI
Just allocation of COVID-19 vaccines
Anders Herlitz, Zohar Lederman, Jennifer Miller +5
Статья2021Цитирований: 2
ABI
Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment
Olivier J. Wouters, Kenneth C. Shadlen, Maximilian Salcher‐Konrad +4
Обзорная статья2021Цитирований: 2
ABI
Risk of mortality in patients infected with SARS-CoV-2 variant of concern 202012/1: matched cohort study
Robert Challen, Ellen Brooks‐Pollock, Jonathan M. Read +3
Статья2021Цитирований: 2
ABI
WHO’s allocation framework for COVAX: is it fair?
Siddhanth Sharma, Nisrine Kawa, Apoorva Gomber
Статья2021Цитирований: 2
ABI
How long does covid-19 immunity last?
Chris Baraniuk
Статья2021Цитирований: 2
ABI
Без названия
ДругоеЦитирований: 1
ABI